Evidence map›Paper›PMID 30592753›Full record

ArticlePloS one2018

A novel variant of torque teno virus 7 identified in patients with Kawasaki disease.

James B Thissen, Mariko Isshiki, Crystal Jaing, Yoshiro Nagao, Dayanara Lebron Aldea, Jonathan E Allen, Masafumi Izui, Thomas R Slezak, Takafumi Ishida, Tetsuya Sano

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Involvement of p53, p21, and Caspase-3 in Apoptosis of Coronary Artery Smooth Muscle Cells in a Kawasaki Vasculitis Mouse Model.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  11. Review
  12. Article
  13. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.Mediterranean journal of hematology and infectious diseases · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James B ThissenLawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0002-4693-5886
Mariko IsshikiDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6565-6970
Crystal JaingLawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0001-9933-3005
Yoshiro NagaoDepartment of Pediatrics, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.ORCID 0000-0003-3411-0729
Dayanara Lebron AldeaLawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0001-6609-1118
Jonathan E AllenLawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0002-4359-8263
Masafumi IzuiDepartment of Pediatrics, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.
Thomas R SlezakLawrence Livermore National Laboratory, Livermore, California, United States of America.
Takafumi IshidaDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.ORCID 0000-0002-0896-3069
Tetsuya SanoDepartment of Pediatrics, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kawasaki disease (KD), first identified in 1967, is a pediatric vasculitis of unknown etiology that has an increasing incidence in Japan and many other countries. KD can cause coronary artery aneurysms. Its epidemiological characteristics, such as seasonality and clinical picture of acute systemic inflammation with prodromal intestinal/respiratory symptoms, suggest an infectious etiology for KD. Interestingly, multiple host genotypes have been identified as predisposing factors for KD. To explore experimental methodology for identifying etiological agent(s) for KD and to optimize epidemiological study design (particularly the sample size) for future studies, we conducted a pilot study. For a 1-year period, we prospectively enrolled 11 patients with KD. To each KD patient, we assigned two control individuals (one with diarrhea and the other with respiratory infections), matched for age, sex, and season of diagnosis. During the acute phase of disease, we collected peripheral blood, nasopharyngeal aspirate, and feces. We also determined genotypes, to identify those that confer susceptibility to KD. There was no statistically significant difference in the frequency of the risk genotypes between KD patients and control subjects. We also used unbiased metagenomic sequencing to analyze these samples. Metagenomic sequencing and PCR detected torque teno virus 7 (TTV7) in two patients with KD (18%), but not in control subjects (P = 0.111). Sanger sequencing revealed that the TTV7 found in the two KD patients contained almost identical variants in nucleotide and identical changes in resulting amino acid, relative to the reference sequence. Additionally, we estimated the sample size that would be required to demonstrate a statistical correlation between TTV7 and KD. Future larger scale studies with carefully optimized metagenomic sequencing experiments and adequate sample size are warranted to further examine the association between KD and potential pathogens, including TTV7.

Indexed as

AllelesBiomarkersChild, PreschoolDisease SusceptibilityDNA Virus InfectionsEvolution, MolecularFemaleGenome, ViralGenomicsGenotypeHumansInfantMaleMetagenomeMetagenomicsMucocutaneous Lymph Node SyndromeBiomarkers

Identifiers

PMID30592753
PMCPMC6310298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.